Antiplatelet Therapy Completed Phase 2 Trials for Ticagrelor (DB08816)

Also known as: Anti-platelet Therapy

IndicationStatusPhase
DBCOND0047920 (Antiplatelet Therapy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03039205Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or TicagrelorTreatment